“
ULTIMATELY, WE WANT THESE THERAPIES TO BE AVAILABLE FOR OUR YOUNGEST PATIENTS. THE SOONER THEY RECEIVE TREATMENT, THE LESS VISION LOSS THEY MAY HAVE TO ENDURE.” — Cagri Besirli, MD, PhD
5
“
ULTIMATELY, WE WANT THESE THERAPIES TO BE AVAILABLE FOR OUR YOUNGEST PATIENTS. THE SOONER THEY RECEIVE TREATMENT, THE LESS VISION LOSS THEY MAY HAVE TO ENDURE.” — Cagri Besirli, MD, PhD
5